VISTAGEN THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Increase Decrease In Operating Lease Liability of -$165.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- VISTAGEN THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$165.00K.
- VISTAGEN THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$100.00K.
- VISTAGEN THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$159.00K.
- VISTAGEN THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$216.00K.
- VISTAGEN THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2026 was -$561.00K.
- VISTAGEN THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$611.00K.
- VISTAGEN THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$495.00K.
- VISTAGEN THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$433.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 3 month as first filed | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month | Increase Decrease In Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$165.00K 10-Q · filed 2026-08-14 | -$265.00K derived: sum of 2 quarters · filed 2026-08-14 | -$424.00K derived: sum of 3 quarters · filed 2026-08-14 | -$640.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | -$259.00K derived: sum of 2 quarters · filed 2026-06-15 | -$475.00K derived: sum of 3 quarters · filed 2026-06-15 | -$561.00K 10-K · filed 2026-06-15 | |||
| 2025-12-31 | -$159.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | -$375.00K derived: sum of 2 quarters · filed 2026-02-12 | -$461.00K 10-Q · filed 2026-02-12 | -$665.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-09-30 | -$216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | -$302.00K 10-Q · filed 2025-11-13 | -$506.00K derived: sum of 3 quarters · filed 2026-08-14 | -$587.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$86.00K 10-Q · filed 2026-08-14 | -$290.00K derived: sum of 2 quarters · filed 2026-08-14 | -$371.00K derived: sum of 3 quarters · filed 2026-08-14 | -$567.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | -$285.00K derived: sum of 2 quarters · filed 2026-06-15 | -$481.00K derived: sum of 3 quarters · filed 2026-06-15 | -$611.00K 10-K · filed 2026-06-15 | |||
| 2024-12-31 | -$81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | -$277.00K derived: sum of 2 quarters · filed 2026-02-12 | -$407.00K 10-Q · filed 2026-02-12 | -$543.00K derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-09-30 | -$196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | -$326.00K 10-Q · filed 2025-11-13 | -$462.00K derived: sum of 3 quarters · filed 2025-11-13 | -$587.00K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$130.00K 10-Q · filed 2025-08-07 | -$266.00K derived: sum of 2 quarters · filed 2025-08-07 | -$391.00K derived: sum of 3 quarters · filed 2025-08-07 | -$511.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | -$136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | -$261.00K derived: sum of 2 quarters · filed 2025-06-17 | -$381.00K derived: sum of 3 quarters · filed 2025-06-17 | -$495.00K 10-K · filed 2025-06-17 | |||
| 2023-12-31 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | -$245.00K derived: sum of 2 quarters · filed 2025-02-13 | -$359.00K 10-Q · filed 2025-02-13 | -$470.50K derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | -$120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | -$234.00K 10-Q · filed 2024-11-07 | -$234.30K 10-Q · filed 2023-11-09 | -$345.50K derived: sum of 3 quarters · filed 2024-11-07 | -$455.00K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$114.00K 10-Q · filed 2024-08-13 | -$114.20K 10-Q · filed 2023-08-10 | -$225.50K derived: sum of 2 quarters · filed 2024-08-13 | -$335.00K derived: sum of 3 quarters · filed 2024-08-13 | -$442.10K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | -$111.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-11 | -$221.00K derived: sum of 2 quarters · filed 2024-06-11 | -$328.10K derived: sum of 3 quarters · filed 2024-06-11 | -$433.00K 10-K · filed 2024-06-11 | -$433.30K 10-K · filed 2023-06-28 | ||
| 2022-12-31 | -$109.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-13 | -$216.60K derived: sum of 2 quarters · filed 2024-02-13 | -$321.50K 10-Q · filed 2024-02-13 | -$424.20K derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2022-09-30 | -$107.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | -$212.00K 10-Q · filed 2023-11-09 | -$314.70K derived: sum of 3 quarters · filed 2023-11-09 | -$714.30K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$104.90K 10-Q · filed 2023-08-10 | -$207.60K derived: sum of 2 quarters · filed 2023-08-10 | -$607.20K derived: sum of 3 quarters · filed 2023-08-10 | -$697.40K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$102.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28 | -$502.30K derived: sum of 2 quarters · filed 2023-06-28 | -$592.50K derived: sum of 3 quarters · filed 2023-06-28 | -$677.00K 10-K · filed 2023-06-28 | |||
| 2021-12-31 | -$399.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-07 | -$489.80K derived: sum of 2 quarters · filed 2023-02-07 | -$574.30K 10-Q · filed 2023-02-07 | -$657.10K derived: sum of 4 quarters · filed 2023-02-07 | |||
| 2021-09-30 | -$90.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10 | -$174.70K 10-Q · filed 2022-11-10 | -$174.70K 10-Q · filed 2021-11-10 | ||||
| 2021-06-30 | -$84.50K 10-Q · filed 2022-08-11 | -$167.30K derived: sum of 2 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | -$82.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | -$313.50K 10-K · filed 2022-06-23 | |||||
| 2020-12-31 | -$230.70K 10-Q · filed 2022-02-10 | ||||||
| 2020-09-30 | -$149.70K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |